These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 2649329
1. Factors associated with fasting and postglucagon plasma C-peptide levels in middle-aged insulin-treated diabetic patients. Laakso M, Rönnemaa T, Sarlund H, Pyörälä K, Kallio V. Diabetes Care; 1989 Feb; 12(2):83-8. PubMed ID: 2649329 [Abstract] [Full Text] [Related]
2. Prevalence of insulin deficiency among initially non-insulin-dependent middle-aged diabetic individuals. Laakso M, Sarlund H, Pyörälä K. Diabetes Care; 1986 Feb; 9(3):228-31. PubMed ID: 3525053 [Abstract] [Full Text] [Related]
3. Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients. Gottsäter A, Landin-Olsson M, Fernlund P, Lernmark A, Sundkvist G. Diabetes Care; 1993 Jun; 16(6):902-10. PubMed ID: 8325204 [Abstract] [Full Text] [Related]
4. Stopping insulin treatment in middle-aged diabetic patients with high postglucagon plasma C-peptide. Effect on glycaemic control, serum lipids and lipoproteins. Laakso M, Sarlund H, Korhonen T, Voutilainen E, Majander H, Hakala P, Uusitupa M, Pyörälä K. Acta Med Scand; 1988 Jun; 223(1):61-8. PubMed ID: 3279723 [Abstract] [Full Text] [Related]
5. Clinical characteristics in the discrimination between patients with low or high C-peptide level among middle-aged insulin-treated diabetics. Laakso M, Sarlund H, Pyörälä K. Diabetes Res; 1987 Feb; 4(2):95-9. PubMed ID: 3581663 [Abstract] [Full Text] [Related]
6. Homogeneity in pattern of decline of beta-cell function in IDDM. Prospective study of 204 consecutive cases followed for 7.4 yr. Snorgaard O, Lassen LH, Binder C. Diabetes Care; 1992 Aug; 15(8):1009-13. PubMed ID: 1505301 [Abstract] [Full Text] [Related]
19. Metabolic control in 131 juvenile-onset diabetic patients as measured by HbA1c: relation to age, duration, C-peptide, insulin dose, and one or two insulin injections. Dahlquist G, Blom L, Bolme P, Hagenfeldt L, Lindgren F, Persson B, Thalme B, Theorell M, Westin S. Diabetes Care; 1982 Sep; 5(4):399-403. PubMed ID: 6759078 [Abstract] [Full Text] [Related]